Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensitive method for endotoxin determination in nanomedicinal product samples.
Giannakou C, Aimonen K, Bloois LV, Catalán J, Geertsma RE, Gremmer ER, de Jong WH, Keizers PH, Schwillens PL, Vandebriel RJ, Park MV. Giannakou C, et al. Among authors: geertsma re. Nanomedicine (Lond). 2019 May;14(10):1231-1246. doi: 10.2217/nnm-2018-0339. Nanomedicine (Lond). 2019. PMID: 31124759
The kinetics of the tissue distribution of silver nanoparticles of different sizes.
Lankveld DP, Oomen AG, Krystek P, Neigh A, Troost-de Jong A, Noorlander CW, Van Eijkeren JC, Geertsma RE, De Jong WH. Lankveld DP, et al. Among authors: geertsma re. Biomaterials. 2010 Nov;31(32):8350-61. doi: 10.1016/j.biomaterials.2010.07.045. Epub 2010 Aug 4. Biomaterials. 2010. PMID: 20684985
Considerations on the EU definition of a nanomaterial: science to support policy making.
Bleeker EA, de Jong WH, Geertsma RE, Groenewold M, Heugens EH, Koers-Jacquemijns M, van de Meent D, Popma JR, Rietveld AG, Wijnhoven SW, Cassee FR, Oomen AG. Bleeker EA, et al. Among authors: geertsma re. Regul Toxicol Pharmacol. 2013 Feb;65(1):119-25. doi: 10.1016/j.yrtph.2012.11.007. Epub 2012 Nov 29. Regul Toxicol Pharmacol. 2013. PMID: 23200793
Horizon scan of nanomedicinal products.
Noorlander CW, Kooi MW, Oomen AG, Park MV, Vandebriel RJ, Geertsma RE. Noorlander CW, et al. Among authors: geertsma re. Nanomedicine (Lond). 2015 May;10(10):1599-608. doi: 10.2217/nnm.15.21. Epub 2015 Feb 19. Nanomedicine (Lond). 2015. PMID: 25694061 Free article.
Nanomedicinal products: a survey on specific toxicity and side effects.
Brand W, Noorlander CW, Giannakou C, De Jong WH, Kooi MW, Park MV, Vandebriel RJ, Bosselaers IE, Scholl JH, Geertsma RE. Brand W, et al. Among authors: geertsma re. Int J Nanomedicine. 2017 Aug 22;12:6107-6129. doi: 10.2147/IJN.S139687. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28883724 Free PMC article.
Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls.
Giannakou C, Park MVDZ, Bosselaers IEM, de Jong WH, van der Laan JW, van Loveren H, Vandebriel RJ, Geertsma RE. Giannakou C, et al. Among authors: geertsma re. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Sep;12(5):e1633. doi: 10.1002/wnan.1633. Epub 2020 Apr 7. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020. PMID: 32266791 Free PMC article. Review.
25 results